ATE450274T1 - Konjugate von n-hydroxypropymethacrylamid- methacrylat-copolymeren mit nuklidaktivierungsagentien und/oder antikrebs- verbindungen - Google Patents

Konjugate von n-hydroxypropymethacrylamid- methacrylat-copolymeren mit nuklidaktivierungsagentien und/oder antikrebs- verbindungen

Info

Publication number
ATE450274T1
ATE450274T1 AT03738319T AT03738319T ATE450274T1 AT E450274 T1 ATE450274 T1 AT E450274T1 AT 03738319 T AT03738319 T AT 03738319T AT 03738319 T AT03738319 T AT 03738319T AT E450274 T1 ATE450274 T1 AT E450274T1
Authority
AT
Austria
Prior art keywords
hydroxypropymethacrylamide
conjugates
nuclide activation
methacrylate copolymers
anticancer compounds
Prior art date
Application number
AT03738319T
Other languages
English (en)
Inventor
Bipin C Patel
Original Assignee
Psimei Pharmaceuticals Plc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Psimei Pharmaceuticals Plc filed Critical Psimei Pharmaceuticals Plc
Application granted granted Critical
Publication of ATE450274T1 publication Critical patent/ATE450274T1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009Neutron capture therapy, e.g. using uranium or non-boron material
    • A61K41/0095Boron neutron capture therapy, i.e. BNCT, e.g. using boronated porphyrins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/009Neutron capture therapy, e.g. using uranium or non-boron material
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Addition Polymer Or Copolymer, Post-Treatments, Or Chemical Modifications (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
AT03738319T 2002-07-22 2003-07-04 Konjugate von n-hydroxypropymethacrylamid- methacrylat-copolymeren mit nuklidaktivierungsagentien und/oder antikrebs- verbindungen ATE450274T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02255107 2002-07-22
PCT/GB2003/002919 WO2004009136A2 (en) 2002-07-22 2003-07-04 Conjugates of n-hydroxypropymethacrylamide-methacrylate copolymer with nuclide activation agent and/or anti-cancer compounds

Publications (1)

Publication Number Publication Date
ATE450274T1 true ATE450274T1 (de) 2009-12-15

Family

ID=30470320

Family Applications (1)

Application Number Title Priority Date Filing Date
AT03738319T ATE450274T1 (de) 2002-07-22 2003-07-04 Konjugate von n-hydroxypropymethacrylamid- methacrylat-copolymeren mit nuklidaktivierungsagentien und/oder antikrebs- verbindungen

Country Status (9)

Country Link
US (1) US7662360B2 (de)
EP (1) EP1534347B1 (de)
JP (1) JP2006502993A (de)
CN (2) CN1678353A (de)
AT (1) ATE450274T1 (de)
AU (2) AU2003250391A1 (de)
CA (1) CA2493252A1 (de)
DE (1) DE60330355D1 (de)
WO (2) WO2004009136A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005115457A2 (en) * 2004-05-10 2005-12-08 University Of Utah Research Foundation Combined active and passive targeting of biologically active agents
EP1797427A4 (de) * 2004-09-22 2009-04-08 Odyssey Thera Inc Verfahren zur identifizierung neuer arzneimittel-leads und neuer therapeutischer verwendungen für bekannte arzneimittel
CA2739757C (en) * 2008-10-07 2016-07-05 Rexahn Pharmaceuticals, Inc. Hpma - docetaxel or gemcitabine conjugates and uses therefore
WO2011008863A2 (en) * 2009-07-14 2011-01-20 Lucia Irene Gonzalez Stereoisomer peptides and their polymer conjugates for hiv disease
CA2779290A1 (en) * 2009-10-29 2011-05-19 Lucia Irene Gonzalez Ligand-targeted multi-stereoisomer peptide polymer conjugates and uses thereof
AU2012305327B2 (en) * 2011-09-05 2016-07-14 Hiroshi Maeda Polymer-type fluorescent molecule probe
JP6253008B2 (ja) * 2013-08-27 2017-12-27 国立大学法人 筑波大学 高分子化ホウ素化合物及びその使用
JP6281991B2 (ja) * 2014-04-11 2018-02-21 国立研究開発法人産業技術総合研究所 ホウ素化合物を内包および外壁に担持するカーボンナノホーン及びその製造方法
CZ308807B6 (cs) * 2015-01-14 2021-06-02 Ústav Organické Chemie A Biochemie Av Čr, V.V.I. Makromolekulární konjugáty pro vizualizaci a separaci proteinů a buněk
CZ308742B6 (cs) * 2015-01-14 2021-04-21 Ústav Organické Chemie A Biochemie Av Čr, V.V.I. Makromolekulární konjugáty pro izolaci, imobilizaci a vizualizaci proteinů
CN105503918A (zh) * 2015-12-08 2016-04-20 南京林业大学 一种含二氧杂戊硼基卟啉锌配合物及其制备方法
CN105777790B (zh) * 2016-05-17 2017-11-14 南京远淑医药科技有限公司 一种邻碳硼烷苯酚衍生物及其制备方法和应用
WO2018071767A1 (en) * 2016-10-14 2018-04-19 University Of Utah Research Foundation Antibody-polymer-drug conjugates
CN107163097B (zh) * 2017-04-20 2020-04-14 童永彭 环磷酸腺苷硼酸络合物及其制备方法,以及抗肿瘤药物和中子俘获治疗的硼剂
WO2019163790A1 (ja) * 2018-02-20 2019-08-29 国立大学法人東京工業大学 p-ボロノフェニルアラニン誘導体及びそれを含む組成物、並びにそれらを製造するためのキット
CN112334158B (zh) * 2018-06-20 2023-10-13 国立大学法人弘前大学 用于硼中子俘获疗法的能够在短时间内选择性地或局部地靶向肿瘤组织的聚集性硼10药剂
WO2020061430A1 (en) * 2018-09-20 2020-03-26 Glyscend, Inc. Boronic acid polymers and methods of use
MX2022003384A (es) 2019-09-20 2022-06-27 Glyscend Inc Polimeros que contienen acido fenil boronico sustituido y metodos de uso.
JP2021063033A (ja) * 2019-10-11 2021-04-22 国立大学法人 東京大学 環状ペプチド

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5856551A (en) * 1993-03-12 1999-01-05 The Regents Of The University Of California Macromolecular structure for boron neutron-capture therapy
US6180766B1 (en) 1993-12-02 2001-01-30 Raymond F. Schinazi Nucleosides and oligonucleotides containing boron clusters
JPH07206690A (ja) * 1994-01-14 1995-08-08 Seitai Kagaku Kenkyusho:Kk 癌治療薬およびその中間体
US6017902A (en) 1999-02-25 2000-01-25 Brookhaven Science Associates Boron containing amino acid compounds and methods for their use

Also Published As

Publication number Publication date
AU2003244843B2 (en) 2008-06-19
AU2003250391A8 (en) 2004-02-09
CN1678353A (zh) 2005-10-05
DE60330355D1 (de) 2010-01-14
WO2004009135A2 (en) 2004-01-29
WO2004009136A2 (en) 2004-01-29
US7662360B2 (en) 2010-02-16
HK1077513A1 (en) 2006-02-17
CA2493252A1 (en) 2004-01-29
JP2006502993A (ja) 2006-01-26
AU2003244843A1 (en) 2004-02-09
EP1534347A2 (de) 2005-06-01
WO2004009136A3 (en) 2004-04-08
US20070258891A1 (en) 2007-11-08
WO2004009135A3 (en) 2004-05-06
CN101524549A (zh) 2009-09-09
AU2003250391A1 (en) 2004-02-09
EP1534347B1 (de) 2009-12-02

Similar Documents

Publication Publication Date Title
ATE450274T1 (de) Konjugate von n-hydroxypropymethacrylamid- methacrylat-copolymeren mit nuklidaktivierungsagentien und/oder antikrebs- verbindungen
ATE507845T1 (de) Polyacetal-arzneimittelkonjugate als freisetzungssystem
ATE296105T1 (de) Iminbildende polysaccharide, deren herstellung und verwendung als zusatzmittel und immunstimulierende mittel
DE60224296D1 (de) Haarpflegezusammensetzungen
WO2008076333A8 (en) Polymer-drug conjugates with tether groups for controlled drug delivery
DE60004172D1 (de) Gcsf konjugate
DE50102595D1 (de) Kosmetisches mittel
TR200102799T2 (tr) Kemokin alıcı bağlayıcı heterosiklik bileşikler
AU4563101A (en) Biodegradable immunomodulatory formulations and methods for use thereof
ATE515290T1 (de) Körperpflegezusammensetzungen mit glycerin und hydroxypropyl-quarternär-ammoniumsalzen
UA103758C2 (ru) Конъюгаты олигомеров инсулина, их композиции и применение
WO2007064345A3 (en) Heterocyclic-substituted bis-1,8 naphthalimide compounds, antibody drug conjugates, and methods of use
DE60323756D1 (de) Pharmazeutisch aktive oligosaccharid-conjugate
WO2006060533A3 (en) Conjugates of 1, 8-bis-naphthalimides with an antibody
WO2008061754A8 (en) Dietary or pharmaceutical compositions containing tricyclic diterpenes and derivatives thereof for the treatment of depression
MX2009006410A (es) Conjugados de polimero-oligonucleotido, proteina y/o peptido.
TW200716151A (en) Polymeric derivative of cytidine metabolic antagonist
ZA202101990B (en) Sulfomaleimide-based linkers and corresponding conjugates
GB0712499D0 (en) Rigid amines
WO2005027828A3 (en) Conjugates of biologically active compounds, methods for their preparation and use, formulation and pharmaceutical applications thereof
TR200401052T4 (tr) Yeni bileşikler
EA200701172A1 (ru) 2-алкокси-3,4,5-тригидроксиалкиламиды, их получение, композиции, их содержащие, и применение
TW200740781A (en) Novel compounds
UA42695C2 (uk) Полімерзв'язаний антрациклін, фармацевтична композиція та проміжна сполука
WO2004014350A3 (en) Polymer conjugates of a local anaesthetic drug

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties